Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions containing the same
US8540990B2 · kind B2 · utility
18Cited by
6References
38Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 11, 2006 |
| Grant date | Sep 24, 2013 |
| Priority date | — |
| Expiry date | Aug 3, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention concerns anti-NGF antibodies (such as anti-NGF antagonist antibodies), and polynucleotides encoding the same. The invention further concerns use of such antibodies and/or polynucleotides in the treatment and/or prevention of pain, including post-surgical pain, rheumatoid arthritis pain, and osteoarthritis pain.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.